Dynamic structures in DNA damage responses & cancer

Tainer, John A.

doi:10.1016/j.pbiomolbio.2015.04.003

Title: Dynamic structures in DNA damage responses & cancer

Full Record
Other Related Research

Authors:: Tainer, John A.

Publication Date:: Sun Mar 01 00:00:00 EST 2015

Sponsoring Org.:: USDOE

OSTI Identifier:: 1295975

Resource Type:: Published Article

Journal Name:: Progress in Biophysics and Molecular Biology

Additional Journal Information:: Journal Name: Progress in Biophysics and Molecular Biology Journal Volume: 117 Journal Issue: 2-3; Journal ID: ISSN 0079-6107

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Tainer, John A. Dynamic structures in DNA damage responses & cancer.  United Kingdom: N. p., 2015. 
Web.  doi:10.1016/j.pbiomolbio.2015.04.003.

Copy to clipboard


                    Tainer, John A. Dynamic structures in DNA damage responses & cancer.  United Kingdom.  https://doi.org/10.1016/j.pbiomolbio.2015.04.003

Copy to clipboard


                    Tainer, John A. Sun .  
"Dynamic structures in DNA damage responses & cancer".  United Kingdom.  https://doi.org/10.1016/j.pbiomolbio.2015.04.003.

Copy to clipboard


                    
@article{osti_1295975,

  title        = {Dynamic structures in DNA damage responses & cancer},

  author       = {Tainer, John A.},

  abstractNote = {},

  doi          = {10.1016/j.pbiomolbio.2015.04.003},

  journal      = {Progress in Biophysics and Molecular Biology},

  number       = 2-3,

  volume       = 117,

  place        = {United Kingdom},

  year         = {Sun Mar 01 00:00:00 EST 2015},

  month        = {Sun Mar 01 00:00:00 EST 2015}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.pbiomolbio.2015.04.003

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 3 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

ZRBA1, a Mixed EGFR/DNA Targeting Molecule, Potentiates Radiation Response Through Delayed DNA Damage Repair Process in a Triple Negative Breast Cancer Model

Journal Article Heravi, Mitra ; Department of Radiation Oncology, McGill University, Montreal ; Segal Cancer Center, Jewish General Hospital, Montreal ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: ZRBA1 is a combi-molecule designed to induce DNA alkylating lesions and to block epidermal growth factor receptor (EGFR) TK domain. Inasmuch as ZRBA1 downregulates the EGFR TK-mediated antisurvival signaling and induces DNA damage, we postulated that it might be a radiosensitizer. The aim of this study was to further investigate the potentiating effect of ZRBA1 in combination with radiation and to elucidate the possible mechanisms of interaction between these 2 treatment modalities. Methods and Materials: The triple negative human breast MDA-MB-468 cancer cell line and mouse mammary cancer 4T1 cell line were used in this study. Clonogenic assay, Westernmore »« less
https://doi.org/10.1016/J.IJROBP.2015.01.026
Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells

Journal Article Wenrui, Duan ; Gao, Li ; Xin, Wu ; ... - Experimental Cell Research

Pirh2, a recently identified ubiquitin-protein ligase, has been reported to promote p53 degradation. Pirh2 physically interacts with p53 and promotes ubiquitination of p53 independently of MDM2. Like MDM2, Pirh2 is thought to participate in an autoregulatory feedback loop that controls p53 function. We have previously reported that Pirh2 was overexpressed in human and murine lung cancers as compared to uninvolved lung tissue. Pirh2 increase could potentially cause degradation of wildtype p53 and reduce its tumor suppression function in the lung tumor cells. Since Pirh2 has been reported to be transactivated by p53, however, the mechanisms by which a high levelmore »« less
https://doi.org/10.1016/j.yexcr.2006.07.005
Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response

Journal Article Yan, Judy ; Father Sean O'Sullivan Research Institute, Hamilton, Ontario, Canada L8N 4A6 ; The Hamilton Centre for Kidney Research ; ... - Experimental Cell Research

Despite the development of chemoresistance as a major concern in prostate cancer therapy, the underlying mechanisms remain elusive. In this report, we demonstrate that DU145-derived prostate cancer stem cells (PCSCs) progress slowly with more cells accumulating in the G1 phase in comparison to DU145 non-PCSCs. Consistent with the important role of the AKT pathway in promoting G1 progression, DU145 PCSCs were less sensitive to growth factor-induced activation of AKT in comparison to non-PCSCs. In response to etoposide (one of the most commonly used chemotherapeutic drugs), DU145 PCSCs survived significantly better than non-PCSCs. In addition to etoposide, PCSCs demonstrated increased resistancemore »« less
https://doi.org/10.1016/J.YEXCR.2014.08.016
Attenuation of the DNA Damage Response by Transforming Growth Factor-Beta Inhibitors Enhances Radiation Sensitivity of Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo

Journal Article Du, Shisuo ; Bouquet, Sophie ; Lo, Chen-Hao ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To determine whether transforming growth factor (TGF)-β inhibition increases the response to radiation therapy in human and mouse non–small-cell lung carcinoma (NSCLC) cells in vitro and in vivo. Methods and Materials: TGF-β–mediated growth response and pathway activation were examined in human NSCLC NCI-H1299, NCI-H292, and A549 cell lines and murine Lewis lung cancer (LLC) cells. Cells were treated in vitro with LY364947, a small-molecule inhibitor of the TGF-β type 1 receptor kinase, or with the pan-isoform TGF-β neutralizing monoclonal antibody 1D11 before radiation exposure. The DNA damage response was assessed by ataxia telangiectasia mutated (ATM) or Trp53 protein phosphorylation, γH2AX foci formation,more »« less
https://doi.org/10.1016/J.IJROBP.2014.09.026
BRIT1 regulates early DNA damage response, chromosomal integrity,and cancer

Journal Article Rai, Rekha ; Dai, Hui ; Multani, Asha S ; ... - Cancer Cell

BRIT1, initially identified as an hTERT repressor, hasadditional functions at DNA damage checkpoints. Here, we demonstratedthat BRIT1 formed nuclear foci minutes after irradiation. The foci ofBRIT1 co-localized with 53BP1, MDC1, NBS1, ATM, RPA, and ATR. BRIT1 wasrequired for activation of these elements, indicating that BRIT1 is aproximal factor in the DNA damage response pathway. Depletion of BRIT1increased the accumulation of chromosomal aberrations. In addition,decreased levels of BRIT1 were detected in several types of human cancerwith BRIT1 expression being inversely correlated with genomic instabilityand metastasis. These results identify BRIT1 as a crucial DNA damageregulator in the ATM/ATR pathways and suggest thatmore »« less
https://doi.org/10.1016/j.ccr.2006.07.002

Similar Records